| Cardiovascular disease (CVD) has been reported as one of the most common comorbidities among patients with severe COVID-19 |
| The established benefits of ACE inhibitors and ARBs in CVD outweigh the uncertain risks among patients at risk of COVID-19 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.